Valuation: Biosenta Inc.

Market Cap 1.51M 1.06M 942K 882K 799K 102M 1.52M 10.59M 4.12M 52.2M 3.98M 3.9M 168M P/E 2024
-1.19x
P/E 2025 -1.59x
Enterprise Value 8.12M 5.71M 5.07M 4.74M 4.3M 550M 8.18M 56.95M 22.15M 281M 21.43M 20.97M 902M EV / Sales 2024
6,101x
EV / Sales 2025 8,809x
Free-Float
88.05%
Yield 2024 *
-
Yield 2025 -
1 day+100.00%
1 week-11.11%
Current month+100.00%
1 month+128.57%
3 months+77.78%
6 months+14.29%
Current year-20.00%
1 week 0.08
Extreme 0.08
0.08
1 month 0.04
Extreme 0.04
0.09
Current year 0.01
Extreme 0.01
0.12
1 year 0.01
Extreme 0.01
0.14
3 years 0.01
Extreme 0.01
0.89
5 years 0.01
Extreme 0.01
0.89
10 years 0
Extreme 0
2.5
Manager TitleAgeSince
Chief Executive Officer - 2019-07-15
Director TitleAgeSince
Chairman 90 2019-07-15
Director/Board Member - 2011-10-04
Chairman 65 2015-02-16
Date Insider Type Main position Quantity % Market Cap. Importance
5/2/26 Option

Chief Executive Officer

-210,000 0.6040%
5/2/26 Option

Director

-807,000 2.3210%
3/3/26 Option

Chief Executive Officer

625,000 1.8139%
Change 5-day change 1-year change 3-year change Capi.($)
+100.00%-11.11%-33.33%-72.41% 2.12M
+1.80%+1.63%-15.64%-17.91% 41.05B
+0.92%+1.67%+8.61%+12.27% 22.69B
+1.84%+2.35%-29.62%-33.18% 9.92B
+0.40%+1.13%-9.05%-11.60% 4.69B
+1.27%-2.45%-13.08%-56.42% 3.34B
+1.09%+1.35%+13.09%+23.20% 3.03B
-0.82%+0.58%+6.58%+0.44% 2.76B
+5.80%+1.28%-26.85%-11.24% 1.66B
-2.65%-5.48%-7.38%+25.44% 1.21B
Average +10.96%-0.35%-10.67%-14.14% 9.03B
Weighted average by Cap. +1.40%+0.96%-9.10%-10.46%

Financials

2024 2025
Net sales 1.38K 969.75 860.85 805.59 730.19 93.48K 1.39K 9.68K 3.76K 47.69K 3.64K 3.56K 153K 1.21K 851.61 755.98 707.45 641.23 82.09K 1.22K 8.5K 3.3K 41.88K 3.2K 3.13K 135K
Net income -2.23M -1.57M -1.39M -1.3M -1.18M -151M -2.24M -15.63M -6.08M -77.04M -5.88M -5.75M -248M -2.51M -1.76M -1.56M -1.46M -1.33M -170M -2.52M -17.58M -6.84M -86.66M -6.61M -6.47M -279M
Net Debt 5.54M 3.9M 3.46M 3.24M 2.94M 376M 5.58M 38.89M 15.13M 192M 14.63M 14.32M 616M 6.61M 4.65M 4.12M 3.86M 3.5M 448M 6.66M 46.36M 18.03M 229M 17.44M 17.07M 735M
Projected Income Statement - Annual - Biosenta Inc.
Logo Biosenta Inc.
Biosenta Inc. is engaged in developing, producing, and manufacturing an array of chemical compounds for household and industrial applications, utilizing advanced encapsulated nanotechnology. It develops antimicrobial products that offer environmentally friendly solutions to a global market. Its flagship product, Tri-Filler, represents an antimicrobial technology, providing durable protection against a wide spectrum of bacteria, molds, and fungi. Tri-filler's Nano-technology particles provide anti-microbial protection while preventing the growth of mold, bacteria and viruses. Tri-filler can be embedded to protect various materials, including drywall, plastic and resin, from microbe formation. These compounds remain active for decades and protect the drywall of buildings, objects such as resin furniture, carpet rubber backing and synthetic tufts containing plastic, resin, textiles and others. Its true disinfectant is recognized by Health Canada for use in the fight against COVID-19.
Employees
-
Date Price Change Volume
26-10-01 $0.0800 +100.00% 21,000